Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
SARS-CoV-2 mutations 'do not increase transmissibility'
Thurs November 26th - None of the SARS-CoV-2 virus mutations that have been documented so far increase transmissibility in humans, a new study has shown. More
Midlife high blood pressure linked to elderly brain damage
Thurs November 26th - High blood pressure in middle age is associated with the development of more extensive brain damage when elderly, researchers report today. More
Activity can offset sedentary lifestyle - WHO says
Thurs November 26th - Exceeding the recommendations for weekly physical activity can offset the health harms associated with prolonged sitting, says new guidelines from the World Health Organisation. More
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 04/08/2020 VICKY P ADAM wrote:
I would like to thank WORLD HERBS CLINIC for reve... on Medieval remedy for bacterial ...
On 29/07/2020 Amdre wrote:
When i read many blogs online about cure to HSV, a... on Medieval remedy for bacterial ...
On 14/07/2020 margret wrote:
I was diagnosed of ALS (amyotrophic lateral sclero... on Heart abnormalities revealed i...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...

Male cancer survivors may need hormone boost

Wednesday November 13th, 2019

Young male cancer survivors may benefit from treatment with replacement testosterone, British experts have reported.

A study was carried out by Professor Richard Ross at the University of Sheffield, UK, and colleagues.

They explain that most cancer research is focused on treating the condition, but they wanted to look at methods to benefit survivors, and this is the first study of its kind to investigate a treatment for one of the late effects of cancer.

About 15% of young male cancer survivors go on to have problems with hormone levels due to chemotherapy and radiotherapy, particularly after treatment for testicular cancer.

The resulting reduced testosterone levels can raise body mass and increase the risk of heart disease.

The new study was published yesterday (12 November) in PLoS Medicine. It was a randomised study of testosterone replacement or placebo in survivors with low testosterone levels.

The 136 participants, aged 25 to 50, took either testosterone or placebo for six months, after which those on the drug lost an average of 1.8kg fat mass and gained 1.5kg in lean body mass.

Professor Ross said: “These late effects of cancer on the health of cancer survivors are increasingly being recognised. The results of this study have significant benefits alongside improvements in body composition, potentially offsetting the risk of increased mortality from heart disease.”

The trial was funded by Cancer Research UK. Dr Aine McCarthy from the charity, commented: “This small study offers a potential way to improve survivors’ quality of life. But this treatment might not be suitable for everyone and we still don’t know how long to give it for, so it will be interesting to see the next steps for this research.”

Ross, R. et al. Testosterone Replacement in Young Male cancer Survivors: A six month double-blind randomised placebo-controlled trial. PLoS Medicine 12 November 2019 doi: 10.1371/journal.pmed.1002960

Tags: Cancer | Men's Health | Pharmaceuticals | UK News

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)